NCT06174571View on ClinicalTrials.gov

Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer.

Not yet recruitingOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

March 1, 2026

Conditions

Breast Cancer

All Listed Sponsors

lead

Assiut University

OTHER

NCT06174571 - Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. | Biotech Hunter | Biotech Hunter